Often diagnosed when surgery is no longer an option, pancreatic cancer is one of the most difficult cancers to treat and has ...

A new CAR T-cell therapy attacks supportive cells in the tumor microenvironment that bear the surface protein, uPAR.

Chimeric antigen receptor T-cell therapy—CAR T for short—has been a major advance in treating blood cancers like leukemia and ...

在探讨当今最具革命性的癌症治疗手段时，嵌合抗原受体T细胞（Chimeric Antigen Receptor T-cell, ...

SMART control of CAR T cells is advancing cancer immunotherapy by improving precision, safety, and adaptability. Why Smart ...

肝脏代谢的一种天然副产物——酮体β-羟基丁酸（β-hydroxybutyrate, BHB），可以增强CAR T细胞的适应性和抗肿瘤活性。这些由Arc研究所和斯坦福大学的科学家，与宾夕法尼亚大学的同事共同完成的研究结果，于2026年3月6日在《细胞》杂志上发表，突显了一种增强癌症 免疫 疗法的潜在新途径。

Global Cell Therapy Market Size, was valued at USD 6.37 Billion in 2025. The market is projected to grow at a robust CAGR of ...

A next-generation "armored" CAR T cell therapy showed promising results in a small study of patients whose B-cell lymphomas continued to resist multiple rounds of other cancer treatments, including ...

Cancer immunotherapy has completely changed our understanding of how cancer can and should be treated. A prime example is chimeric antigen receptor (CAR) T-cell therapy, where T cells are harvested ...